Don Morel and Madhavan Balachandran join Stevanato Group’s Advisory Board
Piombino Dese (Padua, Italy), July 17, 2017 ‒ Italian Stevanato Group is glad to announce that two industry experts have joined the Company to be part of its Advisory Board, the internal body, supporting the CEO on strategic topics linked to the Group vision. The function will be giving independent advice on business opportunities, product portfolio strategy and geographic growth.
Prior to joining Stevanato Group, at their tenure at West Pharma and Amgen respectively, Dr. Donald Morel (also known as Don) and Mr. Madhavan Balachandran (also known as Madhu) have been leading a number of developments in the field of packaging components, delivery systems for injectable drugs and healthcare products as well as biotechnologies.
Donald Morel’s insights on market trends coupled with Madhavan Balachandran’s experience in handling large operations will help lead innovations while ensuring the quality standards and equality at Stevanato Group plants. They have also played a crucial role for the successful transformation of large corporations.
Their experience will be beneficial in the expansion of the Group product portfolio towards high added value systems. After the acquisition of Balda for plastic molding and systems and SVM for assembly, packaging and serialization systems, Stevanato Group is uniquely positioned to offer a whole round solution under the same roof.
Franco Stevanato, CEO of Stevanato Group, commented: “Don and Madhu bring a wealth of experience and will play a crucial role in supporting the growth of our business and establishing us as preferred partner for the development of new pharma projects. I together with our board of directors and management team are looking forward to working with them”.
What is the Stevanato Group Advisory Board
The advisory board is an informal group of opinion leaders and professionals actively supporting the CEO, providing complementary knowledge and experience.
About Dr. Donald E. Morel
Dr. Donald E. Morel served as the Chairman and Chief Executive Officer of West Pharmaceutical Services, Inc. He spearheaded West's efforts to develop novel and proprietary drug delivery technologies. Dr. Morel also serves as a Director of Catalent, Inc. and Integra Life Science Holdings Corporation.
About Mr. Madhavan Balachandran
Mr. Madhavan Balachandran served as an Executive Vice President/Executive Officer of Amgen Inc., Executive Vice President of Operations and Senior Vice President of Manufacturing. Mr. Balachandran is also a Director of Catalent, Inc.
Released July 17, 2017